Key points are not available for this paper at this time.
Although biotech innovations have contributed to improvements in health outcomes, we need more comprehensive health innovation to tackle persistent gender and intersectional equity gaps, argue Karla Unger Saldaña and colleagues
Unger‐Saldaña et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: